These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29272478)

  • 1. Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
    Netz U; Carter J; Eichenberger MR; Feagins K; Galbraith NJ; Dryden GW; Pan J; Rai SN; Galandiuk S
    Inflamm Bowel Dis; 2017 Dec; 24(1):159-165. PubMed ID: 29272478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
    Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
    J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.
    Wu F; Guo NJ; Tian H; Marohn M; Gearhart S; Bayless TM; Brant SR; Kwon JH
    Inflamm Bowel Dis; 2011 Jan; 17(1):241-50. PubMed ID: 20812331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
    Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
    World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating MicroRNA in inflammatory bowel disease.
    Paraskevi A; Theodoropoulos G; Papaconstantinou I; Mantzaris G; Nikiteas N; Gazouli M
    J Crohns Colitis; 2012 Oct; 6(9):900-4. PubMed ID: 22386737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
    Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
    Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
    World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
    Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
    Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
    Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
    Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.
    Lin J; Welker NC; Zhao Z; Li Y; Zhang J; Reuss SA; Zhang X; Lee H; Liu Y; Bronner MP
    Mod Pathol; 2014 Apr; 27(4):602-8. PubMed ID: 24051693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.
    Krissansen GW; Yang Y; McQueen FM; Leung E; Peek D; Chan YC; Print C; Dalbeth N; Williams M; Fraser AG
    Inflamm Bowel Dis; 2015 Mar; 21(3):520-30. PubMed ID: 25628040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease.
    Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M
    Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.